Clinical trial Recruiting at 1 site Interventional Ages 25 to 50 Men only

Evaluating a new sperm-wash device for improving intrauterine insemination outcomes in infertile couples

Official title: The Efficiency of a New Sperm-Wash Device for Intrauterine Insemination in Couples With Infertility

Run by Chung Shan Medical University · NCT06956287 · Data updated 2026-11-12

This study is testing a new sperm-wash device to see if it can help infertile couples have a better chance of getting pregnant through intrauterine insemination.

More Infertility trials

Quick facts

Study typeInterventional
Ages25 Years to 50 Years
SexMen only
Enrollment120 (estimated)
SponsorChung Shan Medical University
Academic / other
Locations1 site (Taichung, Taichung City)
StatusRecruiting
StartedApril 24, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMay 8, 2025
Trial IDNCT06956287 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include males aged 25 to 50 years who are part of a couple diagnosed with infertility and are undergoing IUI treatment.

Probably not a fit

Patients with known female infertility factors requiring more advanced reproductive technologies or severe male factor infertility may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial assesses the effectiveness of a novel sperm-wash device, LensHooke CA0, designed to enhance outcomes in intrauterine insemination (IUI) for couples facing infertility. The study involves 120 couples who will be randomly assigned to either the intervention group using the new device or a control group using traditional density gradient centrifugation (DGC). The primary outcome measured will be the clinical pregnancy rate, while secondary outcomes will include sperm DNA fragmentation. The hypothesis is that the new device will lead to higher pregnancy rates and lower DNA fragmentation compared to conventional methods.

Why it matters

Potential benefit: If successful, this study could lead to improved pregnancy rates for couples undergoing IUI by utilizing a more effective sperm selection method.

How similar studies have gone: While traditional sperm preparation methods have been widely used, this novel approach is relatively untested, making it a potentially innovative advancement in the field.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males aged between 25 to 50 years.
* Part of a couple diagnosed with infertility.
* Undergoing intrauterine insemination (IUI) treatment.
* Sperm concentration \>15 million/mL, progressive motility \>32%, and total motile sperm count \>40 million after wash.
* Willingness of both partners to participate and provide informed consent.

Exclusion Criteria:

* Known female infertility factors requiring assisted reproductive technologies beyond IUI.
* Severe male factor infertility (e.g., oligoasthenoteratozoospermia).
* Use of donor sperm or oocyte.
* Chronic illness or medications affecting sperm quality.
* Prior participation in another clinical trial within the past 3 months.

Where it's running

  • Chung Shan Medical University Hospital
    Taichung, Taichung City, Taiwan
    Recruiting

Study contacts

  • Principal investigator: Tsung-Hsien Lee, M.D., Ph.D. — Chung Shan Medical University
  • Study coordinator: Tsung-Hsien Lee, M.D., Ph.D.
  • Email: jackth.lee@gmail.com
  • Phone: +886920823519

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.